US 2008/0176809 A1Published application

Use of D-ribose to treat cardiac arrhythmias

AssigneeBioenergy, Inc.

InventorJames D. Herrick

Life of this patent

Estimating the term…

Abstract

D-ribose, given in doses of five to 15 grams daily, reduces or prevents the occurrence of atrial fibrillation in persons experiencing atrial fibrillation.

Claims5

Dependent claims

The use of D-ribose to treat atrial fibrillation in persons experiencing atrial fibrillation.

Dependencies are inferred from the claim text.

Facts

Application: 12/009,933Filed 23 Jan 2008
Priority: 23 Jan 2007
Published: 24 Jul 2008
Term ends: Not estimatedThe source records don’t support an estimate.

Classification6 codes

A61K 31/70
Medicinal preparations containing organic active ingredients: carbohydrates; Sugars; Derivatives thereof
A61K 31/7004
Carbohydrates; Sugars; Derivatives thereof: monosaccharides having only carbon, hydrogen and oxygen atoms
A61P 9/00
Drugs for disorders of the cardiovascular system
A61P 9/06
Drugs for disorders of the cardiovascular system: antiarrhythmics

Family

Application60/881,940Us provisional application · filed 23 Jan 2007
US 8,101,581 B2Related patent
US 2008/0176809 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…